Cambridge Investment Research Advisors
CLSD

Cambridge Investment Research Advisors’s Clearside Biomedical CLSD Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-700
Closed -$8K – 3732
2025
Q2 		$8K Hold
700
– – ﹤0.01% 3599
2025
Q1 		$10K Hold
700
– – ﹤0.01% 3483
2024
Q4 		$10K Hold
700
– – ﹤0.01% 3444
2024
Q3 		$13K Hold
700
– – ﹤0.01% 3385
2024
Q2 		$14K Sell
700
-33
-5% -$638 ﹤0.01% 3279
2024
Q1 		$17K Buy
733
+33
+5% +$711 ﹤0.01% 3269
2023
Q4 		$12K Sell
700
-400
-36% -$5.7K ﹤0.01% 3160
2023
Q3 		$14K Sell
1,100
-67
-6% -$1.01K ﹤0.01% 3100
2023
Q2 		$20K Hold
1,167
– – ﹤0.01% 3124
2023
Q1 		$18K Hold
1,167
– – ﹤0.01% 3109
2022
Q4 		$20K Sell
1,167
-566
-33% -$10.2K ﹤0.01% 3042
2022
Q3 		$29K Hold
1,733
– – ﹤0.01% 2981
2022
Q2 		$38K Hold
1,733
– – ﹤0.01% 2963
2022
Q1 		$60K Sell
1,733
-394
-19% -$11.8K ﹤0.01% 3065
2021
Q4 		$88K Sell
2,127
-730
-26% -$47.3K ﹤0.01% 3047
2021
Q3 		$257K Buy
2,857
+844
+42% +$74.5K ﹤0.01% 2589
2021
Q2 		$147K Sell
2,013
-80
-4% -$3.72K ﹤0.01% 2901
2021
Q1 		$78K Buy
2,093
+1,426
+214% +$71.6K ﹤0.01% 2785
2020
Q4 		$27K Buy
+667
New +$17.3K ﹤0.01% 2674

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors's CLSD Position: Q3 2025 in Review

Cambridge Investment Research Advisors sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 700 shares — an estimated $8K sold.

Cambridge Investment Research Advisors first reported a position in CLSD in Q4 2020 and held it in 19 quarters. The position peaked at $257K in Q3 2021. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Cambridge Investment Research Advisors reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 700 Clearside Biomedical shares in Q3 2025, an estimated $8K.
  • Cambridge Investment Research Advisors first reported a position in Clearside Biomedical in Q4 2020 and held it in 19 quarters.
  • Cambridge Investment Research Advisors's Clearside Biomedical position peaked at $257K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.